NR2F1 and prostate carcinoma: Similarly, Jiang et al. identified that the dietary supplement ProstaCaidTM (PC) could repress cell migration and invasiveness in prostate cancer by reducing NR2F1 levels, thus, inhibiting metastatic behavior [52].